Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients

[11] Casaulta-Aebischer C.(1997)Single or multiple daily doses of aminoglycosides: a meta-analysis Chest 112 1208-539

[12] Steinkamp G.(1993)Pharmacokinetics and safety of tobramycin after once-daily administration in patients with cystic fibrosis Klin Paediatr 205 18-309

[13] Wiedemann B.(1998)[Aminoglycosides in patients with mucoviscidosis and pulmonary exacerbation: comparison of once or three times daily administration] TT-Aminoglykoside bei Patienten mit Mukoviszidose und pulmonaler Exazerbation: Vergleich von Einmal- und Dreimalgabe Arch Dis Child 78 536-578

[14] Doering G.(2002)Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for Eur Respir J 19 303-750

[15] Conway S.P.(2005) exacerbations in cystic fibrosis Lancet 365 573-277

[16] Heijerman H.G.(1983)Once-daily tobramycin in the treatment of adult patients with cystic fibrosis J Infect Dis 147 744-1898

[17] Hodson M.E.(1987)Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis-the TOPIC study: a randomised controlled trial Infection 15 270-95

[18] Hoiby N.(1995)Proteases of J Clin Microbiol 33 1896-48

[19] Smyth A.(1983) in patients with cystic fibrosis Bull Eur Physiopathol Respir 19 1-225

[20] Touw D.J.(2003)Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis Pediatr Pulmonol 36 43-86

[11] Casaulta-Aebischer C.(1997)Single or multiple daily doses of aminoglycosides: a meta-analysis Chest 112 1208-539

[12] Steinkamp G.(1993)Pharmacokinetics and safety of tobramycin after once-daily administration in patients with cystic fibrosis Klin Paediatr 205 18-309

[13] Wiedemann B.(1998)[Aminoglycosides in patients with mucoviscidosis and pulmonary exacerbation: comparison of once or three times daily administration] TT-Aminoglykoside bei Patienten mit Mukoviszidose und pulmonaler Exazerbation: Vergleich von Einmal- und Dreimalgabe Arch Dis Child 78 536-578

[14] Doering G.(2002)Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for Eur Respir J 19 303-750

[15] Conway S.P.(2005) exacerbations in cystic fibrosis Lancet 365 573-277

[16] Heijerman H.G.(1983)Once-daily tobramycin in the treatment of adult patients with cystic fibrosis J Infect Dis 147 744-1898

[17] Hodson M.E.(1987)Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis-the TOPIC study: a randomised controlled trial Infection 15 270-95

[18] Hoiby N.(1995)Proteases of J Clin Microbiol 33 1896-48

[19] Smyth A.(1983) in patients with cystic fibrosis Bull Eur Physiopathol Respir 19 1-225

[20] Touw D.J.(2003)Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis Pediatr Pulmonol 36 43-86